Sunovion Respiratory Development Inc.
Quick facts
Marketed products
- Placebo administered by Magnair · Respiratory
Placebo produces no pharmacological effect and serves as a control comparator in clinical trials.
Phase 3 pipeline
- Placebo eFlow (CS) nebulizer · Respiratory
Placebo eFlow (CS) is a vibrating mesh nebulizer device designed to deliver aerosolized medications to the lungs with enhanced efficiency and patient convenience.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sunovion Respiratory Development Inc. portfolio CI brief
- Sunovion Respiratory Development Inc. pipeline updates RSS
Frequently asked questions about Sunovion Respiratory Development Inc.
What are Sunovion Respiratory Development Inc.'s marketed drugs?
Top marketed products include Placebo administered by Magnair.
What is Sunovion Respiratory Development Inc.'s pipeline?
Sunovion Respiratory Development Inc. has 1 drugs in Phase 3, 1 in Phase 2, 3 in Phase 1. Late-stage candidates include Placebo eFlow (CS) nebulizer.
Related
- Placebo administered by Magnair · Respiratory
- Sector hub: All tracked pharma companies